1. Roche's risdiplam deal a relief for SMA rivals Biogen and Novartis--for now— AstraZeneca targets summer start for COVID-19 antibody trial — Keros Therapeutics raises $96M in upsized IPO — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Stock Options - drowning

Discussion in 'Insmed' started by anonymous, Aug 6, 2019 at 4:47 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    We’re under water. Get the lifeboats out
     

  2. anonymous

    anonymous Guest

    The comments on the yahoo (finance) message board are brutal
     
  3. anonymous

    anonymous Guest

    You’re actually surprised by the stock price? This company is horrible with no future. And you have an overpriced antibiotic for a rare disease that rarely gets filled let alone re-filled.
     
  4. anonymous

    anonymous Guest

    ⬆️ You are absolutely correct.
     
  5. anonymous

    anonymous Guest

    Anyone hear the last townhall? where was the silver lining?
     
  6. anonymous

    anonymous Guest

    Left
     
  7. anonymous

    anonymous Guest

    Check out Investor Village
     
  8. anonymous

    anonymous Guest

    For what? That is the most worthless site ever.
     
  9. anonymous

    anonymous Guest

    This Company is going no where! Barely profitable and a measly $29 million in sales 2nd quarter of a recent launch. Zero chance of a buyout. No sales, no technology worth buying, and no future! Nothing to buy! its will stay like this for a long time, just on life support, like a patient in a coma for years on a respirator, not living and not dying, just existing
     
  10. anonymous

    anonymous Guest

    Great analogy. But at least we made record high bonuses for the industry while only banking that $29 mil. The board has to feel good about that. Of course that’s what happens when you get paid just for enrollments. No pull through necessary. Love it!!
     
  11. anonymous

    anonymous Guest

    Ha, so true. We all know of at least one person who made hundreds of thousands on fake enrollment forms. The company used her fake ef’s to bolster numbers to Wall Street...shady bunch of mother f*****
     
  12. anonymous

    anonymous Guest

    When lying and cheating become so imbedded into a culture, where pointing it out gets you labeled a whiner or lazy, it’s time to go. And I’m shining up my whistle.
     
  13. anonymous

    anonymous Guest

    The only thing leadership here is good at is consistently alienating 90% of the sales force with their pathetic lazy IC plan and “promotion” opportunity that is really for a select few reps that live in the right place.